Over 6,000 different rare diseases have been identified to date
Rare diseases currently affect 3.5% – 5.9% of the worldwide population. European Union Commission estimates that the number of EU citizens suffering from a rare disease is 30 million. Based on these data we estimate that approximately 700.000 people suffer from a rare disease in Greece & Cyprus.
Most rare diseases are genetic and have no treatment. About 50% of the patients are children with 30% of them not reaching their fifth birthday.
Due to their low prevalence rare diseases are hard to be diagnosed, while patients need access to effective therapies increasing survival and improving quality of life.
About Orphagen
Our Company
Orphagen is specialized in planning and executing strategies to support entry of orphan drugs in Greek & Cypriot markets, in compliance with the local & international ethics and regulations
Our Mission
To deliver innovative medicines to patients with rare diseases in Greece & Cyprus, providing holistic business solutions
Our Team
Includes committed highly skilled professionals with great experience in launching innovative medications for patients living with rare diseases, in various therapeutic areas
Our Services
Orphagen provides tailored made solutions in order to achieve effective access of patients to orphan drugs.
Marketing Research and Analysis
As experts with deep knowledge of the local markets we could provide our costumer a Market analysis in order to decide the optimum market entry strategy.
Market Access
Orphagen could provide insight and recommendations regarding the optimal pricing and reimbursement strategy.
Medical and Pre-Marketing Activities
Orphagen develops and executes Medical plans providing medical education and scientific communication with all relevant stakeholders
Marketing & Sales
We develop and execute the suitable strategies and tactics to ensure a successful launch and a remarkable penetration of the drug in the market.
Regulatory, PV and Distribution
At Orphagen we fully understand the importance of regulatory & pharmacovigilance compliance and we can provide comprehensive support
Contact Us
Orphagen is always interested to discuss new partnerships to deliver products, fulfilling unmet medical needs, to patients with rare diseases in Greece & Cyprus.
Serving patients suffering from rare diseases
in Greece & Cyprus